Inventor · disambiguated record
Carola Leuschner
Also filed as: LEUSCHNER CAROLA
9 granted patents·12 pending applications·23 citations·filing 2006–2024
84Inventor score
Files withESPERANCE PHARMACEUTICALS INC10LEUSCHNER CAROLA4A28 THERAPEUTICS INC3UNIV LOUISIANA STATE2ALILA HECTOR1
Top patents by PatentIndex Score
21 records- 0186US2025327113A1COMPOSITION FOR DETECTING LHRH OR hCG/LH RECEPTOR EXPRESSING TUMORS, CANCERS AND NEOPLASIASA28 THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0285US2025092092A1Antibody/drug conjugates and methods of useA28 THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0383US8318899B2Lytic domain fusion constructs and methods of making and using sameLEUSCHNER CAROLA·Filed 2009·Granted Nov 27, 2012·7 cites·43 claims
- 0482US10233214B2Antibody/drug conjugates and methods of useESPERANCE PHARMACEUTICALS INC·Filed 2016·Granted Mar 19, 2019·3 cites·28 claims
- 0582US9492563B2Antibody/drug conjugates and methods of useESPERANCE PHARMACEUTICALS INC·Filed 2013·Granted Nov 15, 2016·5 cites·31 claims
- 0682US8546535B2Lytic domain fusion constructs and methods of making and using sameLEUSCHNER CAROLA·Filed 2009·Granted Oct 1, 2013·5 cites·57 claims
- 0777US9586996B2Lytic-peptide-Her2/neu (human epidermal growth factor receptor 2) ligand conjugates and methods of useALILA HECTOR·Filed 2011·Granted Mar 7, 2017·3 cites·47 claims
- 0874US2022048951A1Antibody/drug conjugates and methods of useESPERANCE PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0973US2021324443A1METHODS FOR DIAGNOSING LHRH OR hCG/LH RECEPTOR EXPRESSING TUMORS, CANCERS AND NEOPLASIASESPERANCE PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1069US11066693B2Methods for diagnosing LHRH or hCG/LH receptor expressing tumors, cancers and neoplasiasESPERANCE PHARMACEUTICALS INC·Filed 2018·Granted Jul 20, 2021·0 cites·18 claims
- 1164US10729740B2Lytic-peptide-Her2/neu (Human Epidermal growth factor Receptor 2) ligand conjugates and methods of useESPERANCE PHARMACEUTICALS INC·Filed 2017·Granted Aug 4, 2020·0 cites·20 claims
- 1263US2020353032A1Lytic-peptide-her2/neu (human epidermal growth factor receptor 2) ligand conjugates and methods of useESPERANCE PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1362US2019367558A1Antibody/drug conjugates and methods of useESPERANCE PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1459US9255134B2Lytic domain fusion constructs and methods of making and using sameESPERANCE PHARMACEUTICALS INC·Filed 2013·Granted Feb 9, 2016·0 cites·35 claims
- 1554US10093961B2Methods for diagnosis of and predicting treatment efficacy of hormone receptor expressing tumors, cancers and neoplasiasLEUSCHNER CAROLA·Filed 2010·Granted Oct 9, 2018·0 cites·5 claims
- 1653US2024228542A1Lytic domain fusion constructs, checkpoint inhibitors, and methods of making and using sameA28 THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1749US2009061006A1Layered Nanoparticles for Sustained Release of Small MoleculesLEUSCHNER CAROLA·Filed 2007·Application pending·0 cites
- 1846US2009169478A1In Vivo Imaging and Therapy with Magnetic Nanoparticle ConjugatesUNIV LOUISIANA STATE·Filed 2006·Application pending·0 cites
- 1944US2019241660A1Immune-stimulating peptides and checkpoint inhibitors, and uses thereof for treating cancerINTENDET SERVICES LLC·Filed 2018·Application pending·0 cites
- 2043US2014161767A1Follicle-stimulating hormone (fsh)/lytic domain fusion constructs and methods of making and using sameUNIV LOUISIANA STATE·Filed 2013·Application pending·0 cites
- 2135US2011124564A1Nucleolin-binding peptides, nucleolin- binding lytic peptides, fusion constructs and methods of making and using sameESPERANCE PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Carola Leuschner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →